Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism

被引:16
|
作者
Tohma, Yusuf [1 ]
Akturk, Mujde [1 ]
Altinova, Alev [1 ]
Yassibas, Emine [3 ]
Cerit, Ethem Turgay [1 ]
Gulbahar, Ozlem [2 ]
Arslan, Metin [1 ]
Sanlier, Nevin [3 ]
Toruner, Fusun [1 ]
机构
[1] Gazi Univ, Fac Med, Dept Endocrinol & Metab, TR-06510 Ankara, Turkey
[2] Gazi Univ, Fac Med, Dept Biochem, TR-06510 Ankara, Turkey
[3] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-06510 Ankara, Turkey
关键词
THYROTROPIN-RELEASING-HORMONE; ENERGY-BALANCE; THYROID-HORMONES; BODY-COMPOSITION; ADIPOSE-TISSUE; BROWN FAT; GHRELIN; LEPTIN; RATS; HYPOTHALAMUS;
D O I
10.1089/thy.2014.0515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is insufficient information about the appetite-related hormones orexin-A, nesfatin-1, agouti-related peptide (AgRP), and neuropeptide Y (NPY) in hyperthyroidism. The aim of the present study was to investigate the effects of hyperthyroidism on the basal metabolic rate (BMR) and energy intake, orexin-A, nesfatin-1, AgRP, NPY, and leptin levels in the circulation, and their relationship with each other and on appetite. Methods: In this prospective study, patients were evaluated in hyperthyroid and euthyroid states in comparison with healthy subjects. Twenty-one patients with overt hyperthyroidism and 33 healthy controls were included in the study. Results: Daily energy intake in the hyperthyroid state was found to be higher than that in the euthyroid state patient group (p=0.039). BMR was higher in hyperthyroid patients than the control group (p=0.018). Orexin-A was lower and nesfatin-1 was higher in hyperthyroid patients compared to the controls (p<0.001), whereas orexin-A increased and nesfatin-1 decreased after euthyroidism (p=0.003, p<0.001). No differences were found in the AgRP, NPY, and leptin levels between the hyperthyroid and euthyroid states and controls (p>0.05). Orexin-A correlated negatively with nesfatin-1 (p=0.042), BMR (p=0.013), free triiodothyronine (fT3; p<0.001), and free thyroxine (fT4; p<0.001) and positively with thyrotropin (TSH; p<0.001). Nesfatin-1 correlated negatively with orexin-A (p=0.042) and TSH (p<0.001) and positively with fT3 (p=0.005) and fT4 (p=0.001). In the regression analysis, diagnosis of hyperthyroidism was the main factor affecting orexin-A (p<0.001). Conclusions: Although it seems that no relationship exists among orexin-A, nesfatin-1, and increased appetite in hyperthyroidism, the orexin-A and nesfatin-1 levels are markedly affected by hyperthyroidism.
引用
收藏
页码:776 / 783
页数:8
相关论文
共 38 条
  • [21] The relations of circulating agouti-related peptide and leptin with altered sleep architecture in patients with active Cushing's disease: a pilot study
    Sulu, C.
    Senel, G. B.
    Koca, O.
    Alaylioglu, M.
    Demir, A. N.
    Durcan, E.
    Ak, D. G.
    Dursun, E.
    Konukoglu, D.
    Ozkaya, H. M.
    Karadeniz, D.
    Kadioglu, P.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (01) : 167 - 178
  • [22] Neuropeptide Y-Agouti related peptide ratio (NAR) in patients with idiopathic primary hypothyroidism: Nudge and Risk
    Al-Kuraishy, Hayder Mutter
    Al-Bdulhadi, May Hassan
    Al-Gareeb, Ali Ismail
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (12) : S27 - S31
  • [23] The relations of circulating agouti-related peptide and leptin with altered sleep architecture in patients with active Cushing’s disease: a pilot study
    C. Sulu
    G. B. Senel
    O. Koca
    M. Alaylioglu
    A. N. Demir
    E. Durcan
    D. G. Ak
    E. Dursun
    D. Konukoglu
    H. M. Ozkaya
    D. Karadeniz
    P. Kadioglu
    Journal of Endocrinological Investigation, 2024, 47 : 167 - 178
  • [24] Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) α to ERβ in clonal hypothalamic neurons
    Titolo, Danny
    Cai, Fang
    Belsham, Denise D.
    MOLECULAR ENDOCRINOLOGY, 2006, 20 (09) : 2080 - 2092
  • [25] Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats
    Shimizu, Hiroshi
    Arima, Hiroshi
    Watanabe, Minemori
    Goto, Motomitsu
    Banno, Ryoichi
    Sato, Ikuko
    Ozaki, Nobuaki
    Nagasaki, Hiroshi
    Oiso, Yutaka
    ENDOCRINOLOGY, 2008, 149 (09) : 4544 - 4553
  • [26] Expression of agouti-related peptide, neuropeptide Y, pro-opiomelanocortin and the leptin receptor isoforms in fetal mouse brain from pregnant dams on a protein-restricted diet
    Terroni, PL
    Anthony, FW
    Hanson, MA
    Cagampang, FRA
    MOLECULAR BRAIN RESEARCH, 2005, 140 (1-2): : 111 - 115
  • [27] Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose
    Hao, Lihong
    Sheng, Zhenyu
    Potian, Joseph
    Deak, Adam
    Rohowsky-Kochan, Christine
    Routh, Vanessa H.
    BRAIN RESEARCH, 2016, 1648 : 181 - 192
  • [28] Association Between Adiposity and Fasting Serum Levels of Appetite-regulating Peptides: Leptin, Neuropeptide Y, Desacyl Ghrelin, Peptide YY(1-36), Obestatin, Cocaine and Amphetamine-regulated Transcript, and Agouti-related Protein in Nonobese Participants
    Lucka, Anna
    Wysokinski, Adam
    CHINESE JOURNAL OF PHYSIOLOGY, 2019, 62 (05): : 217 - 225
  • [29] Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis
    Basoglu, Cengiz
    Oner, Ozgur
    Gunes, Cengiz
    Semiz, Umit B.
    Ates, Alpay M.
    Algul, Ayhan
    Ebrinc, Servet
    Cetin, Mesut
    Ozcan, Omer
    Ipcioglu, Osman
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (03) : 165 - 171
  • [30] Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome
    Varli, Bulut
    Sukur, Yavuz Emre
    Ozmen, Batuhan
    Erguder, Berrin Imge
    Sonmezer, Murat
    Berker, Bulent
    Atabekoglu, Cem
    Aytac, Rusen
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2021, 48 (04): : 368 - 373